Inventor · disambiguated record
Mark Daris
Also filed as: DARIS MARK · DARIS MARK E
7 granted patents·4 pending applications·22 citations·filing 2015–2022
80Inventor score
Top patents by PatentIndex Score
11 records- 0196US11254726B2LILRB1-based chimeric antigen receptorA2 BIOTHERAPEUTICS INC·Filed 2021·Granted Feb 22, 2022·16 cites·16 claims
- 0290US12195513B2LILRB1-based chimeric antigen receptorA2 BIOTHERAPEUTICS INC·Filed 2022·Granted Jan 14, 2025·1 cites·18 claims
- 0390US12187775B2LILRB1-based chimeric antigen receptorA2 BIOTHERAPEUTICS INC·Filed 2022·Granted Jan 7, 2025·1 cites·38 claims
- 0483US11466079B2C-terminal antibody variantsAMGEN INC·Filed 2019·Granted Oct 11, 2022·3 cites·25 claims
- 0579US12037377B2LILRB1-based chimeric antigen receptorA2 BIOTHERAPEUTICS INC·Filed 2022·Granted Jul 16, 2024·0 cites·24 claims
- 0673US11858983B2C-terminal anti-sclerostin antibody variantsAMGEN INC·Filed 2022·Granted Jan 2, 2024·0 cites·24 claims
- 0771US2023029341A1Nucleic acid encoding lilrb1-based chimeric antigen receptorA2 BIOTHERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 0863US10202616B2Promoter and regulatory elements for improved expression of heterologous genes in host cellsAMGEN INC·Filed 2015·Granted Feb 12, 2019·1 cites·10 claims
- 0959US2024335471A1Vector systems for delivery of two polynucleotides and methods of making and using sameA2 BIOTHERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1049US2022389075A1Engineered t cell receptors and uses thereofA2 BIOTHERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1148US2022389119A1ENGINEERING CHARGE PAIR MUTATIONS FOR PAIRING OF HETERO-IgG MOLECULESAMGEN INC·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Mark Daris files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →